Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.09 | 0.8 |
mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.8 |
mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.021 | 0.8 |
mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |
mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |